Lack of Association of Polymorphisms in IL22 and IL22RA1 Genes with Fibrosis Severity in Patients with Chronic Hepatitis C

Viral Immunol. 2022 Sep;35(7):509-513. doi: 10.1089/vim.2022.0034. Epub 2022 Jul 15.

Abstract

The IL-22 pathway has been shown to play an important role in the pathogenesis of liver fibrosis. However, little is known about the role of single-nucleotide polymorphisms (SNPs) in IL-22-related genes in relation to the severity of liver fibrosis. This study aimed to investigate the association of polymorphisms in IL22 and IL22RA1 genes with the severity of liver fibrosis in patients with chronic hepatitis C. A total of 326 patients (165 with mild fibrosis and 161 with severe fibrosis) were included. Four SNPs in IL22 (rs1179251, rs2227473, rs1012356, and rs2227485) and two in IL22RA1 (rs4648936 and rs3795299) were evaluated by real-time PCR. No significant association was observed between the polymorphisms studied and the severity of liver fibrosis. The SNPs rs1179251, rs2227473, rs1012356, and rs2227485 in IL22 and rs4648936 and rs3795299 in IL22RA1 may not be involved in the pathogenesis of liver fibrosis in patients with chronic hepatitis C.

Keywords: HCV; IL-22; fibrosis; interleukin; polymorphism.

MeSH terms

  • Fibrosis
  • Genotype
  • Hepatitis C, Chronic* / genetics
  • Hepatitis C, Chronic* / pathology
  • Humans
  • Interleukin-22
  • Interleukins* / genetics
  • Interleukins* / metabolism
  • Liver Cirrhosis* / genetics
  • Liver Cirrhosis* / pathology
  • Polymorphism, Single Nucleotide
  • Receptors, Interleukin* / genetics
  • Receptors, Interleukin* / metabolism

Substances

  • interleukin-22 receptor
  • Interleukins
  • Receptors, Interleukin